浅析跨国制药企业在华研发机构的溢出效应  

Brief Analysis on the Spillover Effects of Multinational Pharmaceutical Enterprises'Research&Devel-opment Institutions in China

作　　者：唐玲[1] 邱家学[1] 

机构地区：[1]中国药科大学国际医药商学院,南京市210009

出　　处：《中国药房》2005年第9期649-651,共3页China Pharmacy

摘　　要：目的促进跨国制药企业研发机构溢出效应在我国的发挥。方法分析跨国制药企业研发机构溢出效应发挥的途径及主要制约因素,提出增强溢出效应的对策。结果与结论我国应增强国内制药企业的吸收能力,促进跨国制药企业与国内制药企业间的人员流动,积极加入跨国制药企业的研发体系,加强知识产权保护及大力推动跨国制药企业对我国的研发投资。OBJECTIVE:To bring the spillover effects of multinational pharmaceutical enterprises'Research&Develop-ment institutions intofull play in China.METHODS:The routes for the exertion of spillover effects and the main restrictive factors of multinational pharmaceutical enterprises were analyzed and some strategies to enhance the spillover effects were put forward.RESULTS&CONCLUSION:The absorbing ability of the domestic pharmaceutical enterprises should be enhanced in China;the flow of the personnel between the multinational enterprises and the domestic pharmaceutical enterprises should be accelerated.We should participate actively in the Research&Development system of multinational pharmaceutical enterprises,reinforce the protection of intellectual property and promote the Research&Development investment of multinational phar-maceutical enterprises in China.

关 键 词：跨国制药企业 研发机构 溢出效应 

分 类 号：F40[经济管理—产业经济] F41